Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥59.19 |
52 Week High | CN¥68.96 |
52 Week Low | CN¥40.52 |
Beta | 0.43 |
1 Month Change | 14.07% |
3 Month Change | 9.98% |
1 Year Change | 0.41% |
3 Year Change | 136.85% |
5 Year Change | 96.12% |
Change since IPO | 121.77% |
Recent News & Updates
Recent updates
Shareholder Returns
999 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -1.4% | 4.5% | 2.2% |
1Y | 0.4% | -13.4% | -14.2% |
Return vs Industry: 000999 exceeded the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 000999 exceeded the CN Market which returned -14.2% over the past year.
Price Volatility
999 volatility | |
---|---|
999 Average Weekly Movement | 4.8% |
Pharmaceuticals Industry Average Movement | 7.6% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 000999 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000999's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 20,318 | n/a | www.999.com.cn |
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in the People’s Republic of China and internationally. It also provides related health services.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Fundamentals Summary
999 fundamental statistics | |
---|---|
Market cap | CN¥58.49b |
Earnings (TTM) | CN¥3.07b |
Revenue (TTM) | CN¥25.68b |
19.1x
P/E Ratio2.3x
P/S RatioIs 999 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
999 income statement (TTM) | |
---|---|
Revenue | CN¥25.68b |
Cost of Revenue | CN¥12.21b |
Gross Profit | CN¥13.47b |
Other Expenses | CN¥10.41b |
Earnings | CN¥3.07b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 3.10 |
Gross Margin | 52.47% |
Net Profit Margin | 11.94% |
Debt/Equity Ratio | 11.3% |
How did 999 perform over the long term?
See historical performance and comparison